Difference between revisions of "Template:Dependence treatment"
Jump to navigation
Jump to search
imported>Tom (LT) m (per Template_talk:Medicine_navs#Background_colours, remove unnecessary and confusing background colours using AWB) |
imported>NSH002 (tidy up) |
||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Antiaddictives |
| − | | title = [[Substance dependence#Anti-addictive drugs|Antiaddictive]]s ([[ATC code N07#N07B|N07B]]) | + | | title = [[Substance dependence#Anti-addictive drugs|Antiaddictive]]s ([[ATC code N07#N07B|N07B]]) |
| − | | state = {{{state|autocollapse}}} | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| − | |listclass = hlist | + | | listclass = hlist |
| − | | group1 = [[Nicotine dependence]] | + | | group1 = [[Nicotine dependence]] |
| − | | | + | | list1 = |
* [[Bupropion]] | * [[Bupropion]] | ||
* [[Varenicline]] | * [[Varenicline]] | ||
| Line 14: | Line 14: | ||
* ''[[Adrenergic agonist|AA]]'' ([[Clonidine]]) | * ''[[Adrenergic agonist|AA]]'' ([[Clonidine]]) | ||
| − | | group2 = [[Alcohol dependence]] | + | | group2 = [[Alcohol dependence]] |
| − | | | + | | list2 = |
* ''[[Acetaldehyde dehydrogenase|AD inhibitor]]'' ([[Disulfiram]] | * ''[[Acetaldehyde dehydrogenase|AD inhibitor]]'' ([[Disulfiram]] | ||
* [[Calcium carbimide]]) | * [[Calcium carbimide]]) | ||
| Line 25: | Line 25: | ||
* [[Baclofen]] | * [[Baclofen]] | ||
| − | | group3 = [[Opioid dependence]] | + | | group3 = [[Opioid dependence]] |
| − | | | + | | list3 = |
* [[Buprenorphine]] | * [[Buprenorphine]] | ||
* [[Methadone]] | * [[Methadone]] | ||
| Line 33: | Line 33: | ||
* [[Dihydroetorphine]] | * [[Dihydroetorphine]] | ||
* [[Morphine|Morphine (extended-release)]] | * [[Morphine|Morphine (extended-release)]] | ||
| − | * [[Hydromorphone|Hydromorphone (extended-release)]] | + | * [[Hydromorphone|Hydromorphone (extended-release)]] |
* ''[[Adrenergic agonist|AA]]'' ([[Clonidine]] | * ''[[Adrenergic agonist|AA]]'' ([[Clonidine]] | ||
* [[Lofexidine]]) | * [[Lofexidine]]) | ||
* [[Ibogaine]] | * [[Ibogaine]] | ||
| − | | group4 = [[Benzodiazepine dependence]] | + | | group4 = [[Benzodiazepine dependence]] |
| − | | list4 = | + | | list4 = |
* ''[[Adrenergic agonist|AA]]'' ([[Clonidine]]) | * ''[[Adrenergic agonist|AA]]'' ([[Clonidine]]) | ||
* ''[[Benzodiazepine]]s'' ([[Diazepam]] | * ''[[Benzodiazepine]]s'' ([[Diazepam]] | ||
| Line 47: | Line 47: | ||
* ''[[Barbiturate]]s'' ([[Phenobarbital]]) | * ''[[Barbiturate]]s'' ([[Phenobarbital]]) | ||
| − | | group5 = [[Amphetamine dependence]] | + | | group5 = [[Amphetamine dependence]] |
| − | | list5 = | + | | list5 = |
* [[Amphetamine]] | * [[Amphetamine]] | ||
* [[Bupropion]] | * [[Bupropion]] | ||
* [[Topiramate]] | * [[Topiramate]] | ||
| − | | group6 = [[Cocaine dependence]] | + | | group6 = [[Cocaine dependence]] |
| − | | list6 = | + | | list6 = |
* [[Bupropion]] | * [[Bupropion]] | ||
* [[Topiramate]] | * [[Topiramate]] | ||
| − | | belowstyle = background: transparent; padding: 0px; | + | | belowstyle = background: transparent; padding: 0px; |
| − | | below = {{Central nervous system navs}} | + | | below = {{Central nervous system navs}} |
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
| − | [[Category: | + | [[Category:Drug templates by ATC]] |
| − | |||
</noinclude> | </noinclude> | ||
Revision as of 12:03, 2 April 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Dependence treatment|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Dependence treatment|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Dependence treatment|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.